DEA Rules & Proposed Rules

DEA Schedules Clonazolam, Diclazepam, Etizolam, Flualprazolam, and Flubromazolam in Schedule I

The Drug Enforcement Administration (DEA) is permanently scheduling five substances (clonazolam, diclazepam, etizolam, flualprazolam, and flubromazolam) in Schedule I of the Controlled Substances Act. This rule is effective April 1, 2026.

DEA Rule: Registering Emergency Medical Services Agencies

The Drug Enforcement Administration (DEA) has issued a final rule requiring Emergency Medical Services (EMS) agencies to register and handle controlled substances. This rule implements provisions of the Protecting Patient Access to Emergency Medications Act of 2017 and takes effect on March 9, 2026.